Admission Date:  [**2166-9-26**]              Discharge Date:   [**2166-10-1**]  Date of Birth:  [**2104-2-5**]             Sex:   F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 896**] Chief Complaint: Abdominal pain  Major Surgical or Invasive Procedure: Paracentesis ([**2166-9-27**]) ERCP wtih stone fragmente extraction and placement of an 11cm by 10FR Cotton-[**Doctor Last Name **] biliary stent ([**2166-9-28**])   History of Present Illness: 62F with known metastatic pancreatic cancer, notably to the liver causing biliary obstruction s/p ERCP with stent placement [**2166-7-25**] to the left hepatic biliary tree with no opacification of the right biliary tree presenting with increasing abdominal distension and pain with nausea and non-bloody loose stool over the last week.
She first noted increasing abdominal distention approx 2 weeks ago and reports a 5 lb weight gain in the last 2 weeks.
Prior to that, she had had anorexia since her diagnosis in [**Month (only) **], slightly improved with stent placement in [**Month (only) 205**], significantly worse for the last few days.
Also endorses nausea but no emesis, dull diffuse abd pain most pronounced in the epigastric and periumbilical regions.
No radiation or exacerbating/relieving factord.
Endorses light colored loose stool 1x/day for the last week as well, denies BRBPR or melena.
She denies productive cough but does endorse chest congestion.
Endorses chills, denies fevers at home.
Denies CP or LE swelling.
Her symptoms continued to progress and she presented to an OSH ED on [**9-26**].
CTA at outside hospital negative for PE, ?possible pneumonia per report.
CT abdomen showed L intrahepatic ductal dilation, progressive metastases in the liver, new ascites, biliary obstruction.
RUQ U/S showed CBD stent in place, pneumobilia in R liver but no intrahepatic ductal dilation, stable ductal dilation in L liver as compared with previous MRCP in [**Month (only) 205**], no evidence of cholangitis.
CXR showed no significant change from prior, no definite focal consolidation, stable cystic lesions in L lung.
UA showed neg leuks, neg nitrites, 1 WBC, no bacteria.
She was given Ceftriaxone 1 gram, Levofloxacin 750mg IV, Zosyn 4.5 grams, Combivent nebs x2, Tylenol 650mg PR for fever 101 rectally, albumin 5% 12.5 grams.
Upon arrival to the [**Hospital Unit Name 153**], she reports her breathing is improved and she continues to have [**8-13**] abdominal pain.
Denies cough or wheezing.
Denies chest pain, chest pressure, palpitations, or weakness.
Denies dysuria, frequency, or urgency.
Denies rashes or skin changes.
Pancreatic cancer    - Diagnosed [**2166-6-4**]    - Metastatic to liver    - Treatment has included palliative chemo 2.
No known FH of pancreatic or other GI malignancies.
Physical Exam: Admission Exam: Vitals: T: 97.5 BP: 118/70 P: 121 R: 27 O2: 98%RA General: Alert, oriented, chronically ill appearing HEENT: Sclera mildly icteric, MM dry, oropharynx clear, moderate dentition Neck: supple, JVP not elevated, no LAD Lungs: DIffuse very coarse BS on L, scattered wheezes on R with moderate air entry, no crackles CV: Fast but regular, normal S1 + S2, no murmurs, rubs, gallops  Abdomen: soft, distended, diffuse mild TTP, most pronounced in epigastric region, bowel sounds present, no rebound tenderness or guarding, no organomegaly appreciated GU: foley in place Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema  Pertinent Discharge Exam: Abdomen soft with mild distention; not tense; very minimally tender in upper quadrants Skin jaundiced  Pertinent Results: ADMISSION [**2166-9-26**] WBC-27.0*# RBC-3.78* HGB-10.7* HCT-31.9* MCV-84 MCH-28.3 MCHC-33.5 RDW-16.3* NEUTS-95.9* LYMPHS-2.0* MONOS-1.3* EOS-0.6 BASOS-0.1 ALT(SGPT)-74* AST(SGOT)-149* LD(LDH)-243 ALK PHOS-674* AMYLASE-103* TOT BILI-4.0* DIR BILI-3.3* INDIR BIL-0.7 GLUCOSE-142* UREA N-12 CREAT-0.8 SODIUM-134 POTASSIUM-3.5 CHLORIDE-104 TOTAL CO2-19* ANION GAP-15 LACTATE-1.9  DISCHARGE: [**2166-10-1**] BLOOD WBC-11.9* RBC-4.37 Hgb-12.7 Hct-37.1 MCV-85 MCH-29.1 MCHC-34.3 RDW-16.5* Plt Ct-242 Glucose-126* UreaN-11 Creat-0.9 Na-132* K-3.2* Cl-96 HCO3-21* AnGap-18 ALT-45* AST-74* AlkPhos-405* TotBili-4.5* BLOOD Albumin-3.1* Calcium-9.1 Phos-2.1* Mg-1.8  ASCITES  WBC-306* RBC-628* POLYS-25* LYMPHS-41* MONOS-0 MESOTHELI-1* MACROPHAG-33* ASCITES  TOT PROT-2.6 GLUCOSE-140 LD(LDH)-70 ALBUMIN-1.3  Peritoneal fluid cytology: POSITIVE FOR MALIGNANT CELLS.
CBD stent in place with pneumobilia and no intrahepatic biliary ductal dilatation in the right lobe; known left lobe biliary dilatation not well appreciated on this study.
Cholelithiasis with wall edema (nonspecific in the setting of ascites); noMurphy's sign.
Extensive bullous disease is seen on the left with mediastinal shift to the side and elevation of the left hemidiaphragm.
There is some right basilar atelectasis once again seen.
Otherwise the right lung is clear of any focal opacities or consolidations concerning for an infectious process.
SIRS/Sepsis/Cholangitis: Felt to have cholangitis from extrinsic biliary obstruction.
Pancreatic cancer, complicated by:    - Liver metastases    - Biliary obstruction    - Malignant ascites Underwent diagnostic and therapeutic paracentesis with removal of 1.5 liters; fluid was positive for malignant cells.
Anemia: Most likely secondary to of chronic disease given malignancy.
Diabetes type II, controlled without complications.
ProAir HFA 90 mcg/Actuation HFA Aerosol Inhaler Sig: [**1-5**] Inhalation every six (6) hours as needed for shortness of breath or wheezing.
SIRS/sepsis with cholangitis 2.
Pancreatic cancer with liver metastases 3.
Malignant ascites 4.
Discharge Instructions: You were admitted with evidence of infection from an obstructed duct near the gallbladder.
